FDA Clearance Tracker · P180025-S009
MANTA Vascular Closure Device
Last checked: Nov 20, 2026Latest source record: Apr 19, 2021 (this decision)Source: openFDAMethods & limitations
Decided
Apr 19, 2021
Approved
Time to decision
68 days
Received Feb 10, 2021. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P180025-S009
- Device name
- MANTA Vascular Closure Device
- Applicant
- Teleflex Medical, LLC
- Applicant location
- Morrisville, NC
- Received
- Feb 10, 2021
- Decided
- Apr 19, 2021
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P180025
Device type
- Device type
- Device, hemostasis, vascular (MGB)
- Device class
- Class III
- Specialty
- Cardiology
FDA's approval statement
As written in FDA's record.
Approval for the addition of an additional depth locator, size 14F, to be packaged separately from the MANTA Vascular Closure Device.
Source documents
Other decisions for Teleflex Medical, LLC
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K262531 · Decided Oct 27, 2026 · 97 days after receipt
Device type: Instrument, Biopsy (KNW) · GI, Urology & Nephrology
3 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.